Direct-to-consumer health-care startup Ro on Wednesday said its platform will now offer more affordable single-dose vials of the weight loss drug Zepbound through a new partnership with Eli Lilly , which aims to streamline access to the popular treatment.
That is made possible through a first-of-a-kind integration with Eli Lilly's direct-to-consumer website, LillyDirect, which already offers home delivery of Zepbound vials through a third-party digital pharmacy, Gifthealth.
Gifthealth will dispense the vials to patients who receive Zepbound prescriptions through a provider affiliated with Ro.
The vials have the "most affordable" price of a branded GLP-1 drug before insurance, according to Ro.
They can access doctors, labs and a pharmacy that will give them access to Zepbound vials all in one place."
Persons:
Eli Lilly, Ro, Eli Lilly's, Zachariah Reitano, Reitano
Organizations:
Ro, CNBC